![Takashi Sugimoto](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Takashi Sugimoto
Private Equity Investor at SMBC Venture Capital KK
Network origin in Takashi Sugimoto first degree
Entity | Entity type | Industry | |
---|---|---|---|
SMBC Venture Capital KK
![]() SMBC Venture Capital KK Investment ManagersFinance SMBC Venture Capital KK (SMBC Venture Capital) is a Private Equity firm, a subsidiary of Sumitomo Mitsui Banking Corp., itself a subsidiary of publicly traded company Sumitomo Mitsui Financial Group, Inc. (TK:8316) founded in 2005. The firm is headquartered in Tokyo.
18
| Subsidiary | Investment Managers | 18 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Takashi Sugimoto via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Sumitomo Mitsui Banking Corp.
![]() Sumitomo Mitsui Banking Corp. Major BanksFinance Sumitomo Mitsui Banking Corp. engages in the provision of financial services centered on banking. It operates through the following business segments: Wholesale, Retail, International, Market Sales, and Headquarters Management. The Wholesale segment covers business for customers of large and medium-sized companies in Japan. The Retail segment handles business for domestic individuals and SME customers. The International segment comprises of business for overseas Japanese and non-Japanese companies. The Market Sales segment corresponds to financial market business. The Headquarters Management segment includes all other businesses not covered by other segments. The company was founded in April 2001 and is headquartered in Tokyo, Japan. | Major Banks | Director/Board Member | |
SUMITOMO MITSUI FINANCIAL GROUP, INC. | Major Banks | Director/Board Member | |
Kyushu University Faculty of Law | College/University | Undergraduate Degree | |
Aoyama Gakuin University | College/University | Graduate Degree | |
RBG Partners KK
![]() RBG Partners KK Investment ManagersFinance RBG Partners KK engages in the operation and management of investment business partnership assets. It also deals with the acquisition and holding of securities and offers consulting services for company diagnosis and investment planning. The company was founded on October 2, 2018 and is headquartered in Yokohama, Japan. | Investment Managers | Director/Board Member | |
ARTham Therapeutics, Inc.
![]() ARTham Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Kaken Pharmaceutical Co., Ltd., ARTham Therapeutics, Inc. is a pharmaceutical company based in Yokohama, Japan. The Japanese company's mission is to deliver "medicines that matter" to improve patient health and contribute to enhanced quality of life through the development of innovative disease-modifying medicines. The company was founded by Sham Nikam, Naoto Uemura, and has been led by CEO Hiroshi Nagabukuro since 2018. ARTham Therapeutics was acquired by Kaken Pharmaceutical Co., Ltd. on December 13, 2021 for $111.95 million. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
Japan | 7 |
Sectoral
Finance | 4 |
Consumer Services | 3 |
Health Technology | 2 |
Operational
Private Equity Investor | 14 |
Director/Board Member | 4 |
President | 3 |
Chief Executive Officer | 1 |
Corporate Officer/Principal | 1 |
Most connected contacts
- Stock Market
- Insiders
- Takashi Sugimoto
- Company connections